Can G-quadruplex become a promising target in HBV therapy?

Area of Science:

• Virology
• Molecular Biology
• Drug Discovery

Background:

• Chronic hepatitis B virus (HBV) infection is a global health concern.
• Existing HBV therapies have limited efficacy, side effects, and require long-term treatment.
• Novel therapeutic strategies targeting HBV are urgently needed.

Purpose of the Study:

• To review recent studies on G-quadruplexes (G4s) in antiviral research.
• To discuss the potential of G4 structures as therapeutic targets for HBV infection.

Main Methods:

• Literature review of antiviral studies focusing on G-quadruplexes.
• Analysis of the role of G4 structures in gene expression and viral replication.
• Exploration of G4s as potential targets in antiviral drug development.

Main Results:

• Non-canonical nucleic acid structures, such as G4s, regulate gene expression.
• G4 formation in G-rich sequences impacts crucial biological processes like replication and transcription.
• G4s have demonstrated potential in anticancer and antiviral therapeutic strategies.

Conclusions:

• G-quadruplex structures represent a promising area for developing novel antiviral therapies against HBV.
• Targeting G4s could overcome limitations of current HBV treatments.
• Further research into G4-based antivirals is warranted for hepatitis B therapy.